Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Shilpa Medicare

BSE: 530549|NSE: SHILPAMED|ISIN: INE790G01031|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 16, 15:55
570.75
-8.35 (-1.44%)
VOLUME 1,292
LIVE
NSE
Aug 16, 15:53
576.65
-3.55 (-0.61%)
VOLUME 16,683
Announcements on Shilpa

10th-Aug-2017 14:29Source: BSE

Shilpa- Outcome of Board Meeting

With reference to the captioned subject, Please find the enclosed documents in terms of Regulation 33 of SEBI (LODR) Regulations, 2015:
1. Un-Audited Standalone and Consolidated Financial Results ...

10th-Aug-2017 13:54Source: BSE

Shilpa- Unaudited Quarterly Financial Results (Standalone & Consolidated) For Quarter Ended 30.06.2017

Shilpa Medicare has informed BSE about:

1. Un-Audited Standalone and Consolidated Financial Results for the first quarter ended 30th June, 2017.

2. Limited Review Report on Standalon...

31st-Jul-2017 18:08Source: BSE

Shilpa- Board Meeting Intimation For Results & Closure Of Trading Window

We wish to inform you that a meeting of Board of Directors will be held on Thursday, the 10th day of August, 2017 inter alia to consider the Un-audited Financial Results for the First Quarter ended 30...

31st-Jul-2017 13:48Source: BSE

Shilpa- Updates

This is to inform you that the US FDA has completed inspection of Company''s formulations manufacturing facility (SEZ unit) located at Jadcherla, Telangana, India which was inspected between 24th July...

20th-Jul-2017 18:07Source: BSE

Shilpa- Shareholding for the Period Ended June 30, 2017

Shilpa Medicare Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly

20th-Jul-2017 15:41Source: BSE

Shilpa- Statement Of Investor Complaints For The Quarter Ended 30.06.2017.

In Compliance with the requirement under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, please find the statement of investor Complaints/Grievances for th...

15th-Jul-2017 16:47Source: BSE

Shilpa- Revised Financial Results For The Quarter And Year Ended 31/03/2017.

With reference to your e-mail, we herewith enclosed the revised financial results for the quarter and year ended 31st March, 2017.

12th-Jul-2017 13:11Source: BSE

Shilpa- Declaration regarding Audit Report

Shilpa Medicare Ltd has informed BSE regarding Declaration regarding Audit Report for Financial Results for Period ended March 31, 2017.

14th-Jun-2017 15:40Source: BSE

Shilpa- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jasvantlal Chhotalal & Co Pvt Ltd

12th-Jun-2017 17:57Source: NSE

Shilpa Medicare Limited

Shilpa Medicare Limited has informed the Exchange regarding Submission of Reconciliation of Equity as on March 31, 2016 for the standalone and consolidated financial results quarter ended March 31, 20...

1 2 3 4 5 Next >>
Quick Links for Shilpa Medicare
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.